Are you at risk for a stroke?

There are a number of factors that increase your risk of TIA/stroke. Some can be treated with medicine or managed by lifestyle changes you and your doctor can discuss. These controllable risk factors include:

Controllable Risk Factors

Other risk factors are beyond your control. These uncontrollable risk factors include:

Uncontrollable Risk Factors: Age, Gender, Race, Heredity, Ethnicity, Prior stroke, TIA, or heart attack

Taking an active role in understanding and managing these risks and consistently following your doctor's advice are the best ways of preventing a disabling stroke.

HOW TO LOWER YOUR RISK:

See your doctor for regular checkups. Your doctor can pinpoint your risk factors and identify the right treatments and lifestyle changes to help reduce your risk of a recurrent TIA or stroke.

WHAT'S RELATED?

You may also be interested in reading:

Get FREE resources on TIA and stroke. Click here

If you can’t afford your AGGRENOX, our patient assistance program may be able to help.
Call 1 800 556 8317.

Important Information about AGGRENOX

AGGRENOX is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

In clinical trials, the most common adverse event with AGGRENOX was headache (38.2% vs 32.4% with placebo), which was more frequent at the onset of therapy but diminished over time. GI bleeding with AGGRENOX was comparable to aspirin (4.1% vs 3.2%) and intracranial hemorrhage with AGGRENOX was similar to placebo (0.6% vs 0.4%).

AGGRENOX contains aspirin. Patients who consume three or more alcoholic drinks every day should be counseled about the bleeding risks involved with chronic, heavy alcohol use while taking aspirin. Even low doses of aspirin can increase bleeding time, which can adversely affect patients with bleeding disorders. Patients with a history of active peptic ulcer disease should avoid using aspirin, which can cause gastric mucosal irritation and bleeding. AGGRENOX should be avoided in the third trimester of pregnancy.

Click here for full AGGRENOX Prescribing Information.